Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.26 USD | +1.40% | +14.52% | +8.84% |
May. 02 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
May. 02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.84% | 1.73B | |
+73.48% | 12.41B | |
-16.86% | 7.87B | |
+7.36% | 6.37B | |
+3.66% | 5.81B | |
+13.79% | 5.36B | |
+40.99% | 4.92B | |
-19.73% | 4.02B | |
-34.51% | 2.43B | |
+0.74% | 2.02B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Evercore ISI Adjusts Price Target on NovoCure to $15 From $14, Keeps In Line Rating